Gene · 3337
Papers2,173
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,173
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. | Sci Adv | 2023 | 37343102 | PubTator, text mining | PubMed |
| The Genetic Architecture of Multimodal Human Brain Age. | bioRxiv | 2023 | 37333190 | PubTator, text mining | PubMed |
| Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression. | Liver Cancer | 2023 | 37325496 | PubTator, text mining | PubMed |
| Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. | Nat Commun | 2023 | 37308489 | PubTator, text mining | PubMed |
| A cytosolic surveillance mechanism activates the mitochondrial UPR. | Nature | 2023 | 37286597 | PubTator, text mining | PubMed |
| Heat shock proteins and metal ions - Reaction or interaction? | Comput Struct Biotechnol J | 2023 | 37273852 | PubTator, text mining | PubMed |
| Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. | MedComm (2020) | 2023 | 37256211 | PubTator, text mining | PubMed |
| Hyperthermia promotes M1 polarization of macrophages via exosome-mediated HSPB8 transfer in triple negative breast cancer. | Discov Oncol | 2023 | 37233869 | PubTator, text mining | PubMed |
| TP53BP1, a dual-coding gene, uses promoter switching and translational reinitiation to express a smORF protein. | iScience | 2023 | 37216125 | PubTator, text mining | PubMed |
| Comparison of prognostic value between CAD-RADS 1.0 and CAD-RADS 2.0 evaluated by convolutional neural networks based CCTA. | Heliyon | 2023 | 37215852 | PubTator, text mining | PubMed |
| Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. | J Hepatocell Carcinoma | 2023 | 37215364 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. | Clin Transl Med | 2023 | 37203239 | PubTator, text mining | PubMed |
| Advances in deciphering the interactions between viral proteins of influenza A virus and host cellular proteins. | Cell Insight | 2023 | 37193064 | PubTator, text mining | PubMed |
| An Integrative Multi-Omics Analysis of The Molecular Links between Aging and Aggressiveness in Thyroid Cancers. | Aging Dis | 2023 | 37191407 | PubTator, text mining | PubMed |
| HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances. | Biomolecules | 2023 | 37189349 | PubTator, text mining | PubMed |
| Transcriptional regulation of Sis1 promotes fitness but not feedback in the heat shock response. | Elife | 2023 | 37158601 | PubTator, text mining | PubMed |
| Stereochemical Control of Splice Modulation in FD-895 Analogues. | J Med Chem | 2023 | 37155693 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. | Nat Commun | 2023 | 37137901 | PubTator, text mining | PubMed |
| An Unusual Case of Hepatocellular Carcinoma in a Healthy Teenager. | J Investig Med High Impact Case Rep | 2023 | 37119001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3337/papers?page=12